Weighted Average Number of Shares Outstanding, Basic of Qualigen Therapeutics, Inc. from Q1 2021 to Q3 2025

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Qualigen Therapeutics, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q1 2021 to Q3 2025.
  • Qualigen Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending September 30, 2025 was 621K shares, a 60% increase year-over-year.
  • Qualigen Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2024 was 362K shares, a 256% increase from 2023.
  • Qualigen Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 101K shares, a 97.4% decline from 2022.
  • Qualigen Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 3.84M shares, a 30.9% increase from 2021.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Weighted Average Number of Shares Outstanding, Basic, Annual (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Annual Growth (%)

Qualigen Therapeutics, Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic (shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 621K +233K +60% Jul 1, 2025 Sep 30, 2025 10-Q 2025-11-14
Q2 2025 1.68M +1.53M +1007% Apr 1, 2025 Jun 30, 2025 10-Q 2025-08-14
Q1 2025 1.46M +1.34M +1125% Jan 1, 2025 Mar 31, 2025 10-Q 2025-07-21
Q4 2024 362K +260K +256% Oct 1, 2024 Dec 31, 2024 10-K 2025-06-30
Q3 2024 388K -4.66M -92.3% Jul 1, 2024 Sep 30, 2024 10-Q 2025-11-14
Q2 2024 152K -4.9M -97% Apr 1, 2024 Jun 30, 2024 10-Q 2025-08-14
Q1 2024 119K -4.84M -97.6% Jan 1, 2024 Mar 31, 2024 10-Q 2025-07-21
Q4 2023 101K -3.74M -97.4% Oct 1, 2023 Dec 31, 2023 10-K 2025-06-30
Q3 2023 5.05M +1.11M +28.1% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-14
Q2 2023 5.05M +1.38M +37.7% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-14
Q1 2023 4.96M +1.43M +40.5% Jan 1, 2023 Mar 31, 2023 10-Q 2024-07-02
Q4 2022 3.84M +907K +30.9% Oct 1, 2022 Dec 31, 2022 10-K 2024-04-08
Q3 2022 3.94M -25.1M -86.4% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 3.67M -25.2M -87.3% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 3.53M -24.6M -87.5% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 2.93M Oct 1, 2021 Dec 31, 2021 10-K 2023-05-02
Q3 2021 29M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 28.9M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 28.2M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-13

Qualigen Therapeutics, Inc. Annual Weighted Average Number of Shares Outstanding, Basic (shares)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 362K +260K +256% Jan 1, 2024 Dec 31, 2024 10-K 2025-06-30
2023 101K -3.74M -97.4% Jan 1, 2023 Dec 31, 2023 10-K 2025-06-30
2022 3.84M +907K +30.9% Jan 1, 2022 Dec 31, 2022 10-K 2024-04-08
2021 2.93M Jan 1, 2021 Dec 31, 2021 10-K 2023-05-02
* An asterisk sign (*) next to the value indicates that the value is likely invalid.